Related Experiment Video
Updated: Aug 24, 2025

04:33
Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
Published on: December 8, 2023
959
Point-of-Care Urinalysis with One Drop of Sample Using an Aggregation-Induced Emission Luminogen under the
Shujuan Guan1, Qiangqiang Fu1, Dong Wang2
1Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou510515, China.
ACS Sensors
|October 26, 2022
Summary
A new point-of-care test enables simultaneous detection of microalbuminuria and leukocytes in urine. This rapid, low-cost device uses a smartphone for early chronic kidney disease (CKD) screening and monitoring.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Clinical Diagnostics
Background:
- Chronic kidney disease (CKD) diagnosis relies on methods unsuitable for resource-limited settings.
- Current urinalysis requires complex equipment and lengthy procedures, hindering point-of-care applications.
- There is a critical need for rapid, accessible diagnostic tools for early CKD detection and management.
Purpose of the Study:
- To develop a practical point-of-care (POC) device for simultaneous quantification of microalbuminuria and leukocyte in urine.
- To create a rapid, low-cost diagnostic tool for early screening and monitoring of chronic kidney disease (CKD).
- To utilize aggregation-induced emission luminogen for sensitive and selective detection.
Main Methods:
- A novel luminogen (TTVP) with aggregation-induced emission properties was employed.
- The device leverages hydrophobic/electrostatic interactions for selective activation of near-infrared fluorescence by albumin and leukocytes.
- Simultaneous detection was achieved using a smartphone-based reader and exploiting the coffee-ring effect for signal separation.
Main Results:
- The POC device successfully quantified urine albumin and leukocyte simultaneously from a single drop of urine.
- The entire detection process, including quantification, was completed within 20 minutes.
- Validation with 120 clinical samples confirmed the system's performance and reliability.
Conclusions:
- A simple, low-cost, and rapid POC test for simultaneous microalbuminuria and leukocyte detection has been developed.
- This technology offers a promising tool for point-of-care CKD screening and disease monitoring.
- The developed device addresses limitations of traditional methods, enabling wider accessibility in healthcare settings.

